Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsBal pharma

    Bal Pharma

    Jump to

    • Bal Pharma Consolidated September 2025 Net Sales at Rs 74.02 crore, up 0.45% Y-o-Y

    • Bal Pharma Standalone September 2025 Net Sales at Rs 73.75 crore, down 1.27% Y-o-Y

    • Bal Pharma Standalone June 2025 Net Sales at Rs 65.64 crore, down 10.25% Y-o-Y

    • Bal Pharma Standalone March 2025 Net Sales at Rs 81.78 crore, down 13.53% Y-o-Y

    • Bal Pharma Consolidated March 2025 Net Sales at Rs 81.88 crore, down 13.47% Y-o-Y

    • Bal Pharma Consolidated December 2024 Net Sales at Rs 73.15 crore, down 10.42% Y-o-Y

    • Bal Pharma Consolidated September 2024 Net Sales at Rs 73.69 crore, down 20.37% Y-o-Y

    • Bal Pharma Standalone September 2024 Net Sales at Rs 74.70 crore, down 19.07% Y-o-Y

    • Bal Pharma Consolidated June 2024 Net Sales at Rs 74.36 crore, up 5.64% Y-o-Y

    • Bal Pharma Standalone June 2024 Net Sales at Rs 73.13 crore, up 4.22% Y-o-Y

    • Bal Pharma Consolidated March 2024 Net Sales at Rs 94.63 crore, up 14.77% Y-o-Y

    • Bal Pharma Standalone March 2024 Net Sales at Rs 94.58 crore, up 15.38% Y-o-Y

    • Bal Pharma Consolidated December 2023 Net Sales at Rs 81.66 crore, up 6.58% Y-o-Y

    • Bal Pharma Standalone December 2023 Net Sales at Rs 81.49 crore, up 6.44% Y-o-Y

    • Bal Pharma Standalone September 2023 Net Sales at Rs 92.30 crore, up 22.98% Y-o-Y

    • Bal Pharma Consolidated June 2023 Net Sales at Rs 70.39 crore, up 0.78% Y-o-Y

    • Bal Pharma Standalone June 2023 Net Sales at Rs 70.17 crore, up 0.94% Y-o-Y

    • Bal Pharma Consolidated March 2023 Net Sales at Rs 82.45 crore, up 11.35% Y-o-Y

    • Bal Pharma Standalone March 2023 Net Sales at Rs 81.97 crore, up 11.13% Y-o-Y

    • Bal Pharma Consolidated December 2022 Net Sales at Rs 76.62 crore, up 10.77% Y-o-Y

    • Bal Pharma Standalone December 2022 Net Sales at Rs 76.56 crore, up 10.97% Y-o-Y

    • Bal Pharma Consolidated September 2022 Net Sales at Rs 75.31 crore, up 12.11% Y-o-Y

    • Bal Pharma Standalone June 2022 Net Sales at Rs 69.51 crore, down 1.56% Y-o-Y

    • Bal Pharma Consolidated March 2022 Net Sales at Rs 74.05 crore, up 4.57% Y-o-Y

    • Trade Spotlight | What should you do with DLF, Birla Cable, Firstsource, Orient Bell, Bal Pharma?

      Birla Cable has consolidated from August 2021 till January 2022. Recently the counter has a clean weekly breakout on triangle pattern with moving average convergence divergence (MACD) giving positive crossover above zero which is indicating that the stock is ready for up move.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347